Pandemic preparedness involves comprehensive planning and coordination to mitigate the impact of global health crises caused by infectious diseases. It encompasses strategies at local, national, and international levels to enhance surveillance, response capabilities, and public health infrastructure. Key components of pandemic preparedness include early detection through surveillance systems, rapid response mechanisms, development and stockpiling of vaccines and antiviral medications, and communication strategies to disseminate accurate information to the public. Global organizations, such as the World Health Organization (WHO), play a vital role in coordinating international efforts and providing guidance for pandemic preparedness. Collaborations between governments, public health agencies, research institutions, and pharmaceutical companies are essential to address emerging threats. Lessons learned from previous pandemics, such as the H1N1 influenza pandemic and the COVID-19 pandemic, underscore the need for continuous improvement in preparedness strategies. Ongoing research focuses on developing new technologies, improving vaccine platforms, and refining response protocols to enhance global readiness for potential future pandemics.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States